#TBT – Scleroderma: Interview with Ann Havelock

Recent Posts

• Phase 2 trial testing nemolizumab for SSc slated to launch soon
• Immune cells linked to kidney, lung complications in SSc: Study
• Why scleroderma awareness is important to me
• CAR T-cell therapy rese-cel shows early efficacy in systemic sclerosis
• Pulmonary hypertension may be scleroderma marker of prognosis
• Scleroderma community gears up for awareness month in June
• Heart fibrosis may contribute to sudden death in systemic sclerosis
• Ofev consistently slows lung function decline in SSc-ILD: Study
• Large study IDs risks for primary heart involvement in scleroderma
• Age, sex, socioeconomics tied to localized scleroderma risk: Study